Skip to main content
FinSpry Logo
FinSpry
CMPX logo
CMPX
(NASDAQ)
Compass Therapeutics, Inc.
$2.15-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Compass Therapeutics (CMPX) Stock Price & Financial Analysis

Compass Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.11 - $2.23
52-Week High$6.88
52-Week Low$1.61
Open$2.15
Volume4.19M
Average Volume (3M)2.83M
Market Cap400.76M
Shares Outstanding186.40M
Price to Book (P/B)2.15
EV/EBITDA-5.07
50-Day MA$2.10
200-Day MA$4.15
52-Week Change-20.37%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Compass Therapeutics

What is the current stock price for CMPX?

As of the latest trading session, CMPX stock trades at $2.22. The 52-week range is $1.61–$6.88, with a day range of $2.11–$2.23.

What is the P/E ratio for CMPX?

The P/E ratio (Price-to-Earnings) for CMPX is shown in the Key Statistics section. This valuation metric helps compare Compass Therapeutics, Inc. to industry peers.

Does CMPX pay dividends?

Compass Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CMPX?

Based on 4 analysts, the consensus for CMPX is Buy.

What is the market cap of CMPX?

Compass Therapeutics's market capitalization is $413.8M, classifying it as a small-cap company. Compass Therapeutics operates in the Healthcare sector within the Biotechnology industry.